Trials / Unknown
UnknownNCT05464147
DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions
DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions (DYNAMITE Study)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Elixir Medical Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioadaptor System implantation in complex coronary lesions.
Conditions
- Coronary Artery Disease
- Chronic Total Occlusion of Coronary Artery
- Bifurcation of Coronary Artery
- Multi Vessel Coronary Artery Disease
- Long Lesions Coronary Artery Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DynamX Drug-Eluting Coronary Bioadaptor System | DynamX Drug-Eluting Coronary Bioadaptor System Implantation in Coronary Artery Lesion |
Timeline
- Start date
- 2021-10-19
- Primary completion
- 2024-03-01
- Completion
- 2024-10-01
- First posted
- 2022-07-19
- Last updated
- 2023-09-21
Locations
1 site across 1 country: Italy
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05464147. Inclusion in this directory is not an endorsement.